Notice of intent for sole source procurement of respiratory syncytial virus (RSV) Modeling, Cost Assessments, and Health Utility Analyses
The Centers for Disease Control and Prevention published a Notice of intent for sole source procurement of respiratory syncytial virus modeling, cost assessments, and health utility analyses. The CDC awarded a contract to the Regents of the University of Michigan to perform RSV modeling, cost assessments, and health utility analyses to inform the Advisory Committee on Immunization Practices' decision making on the cost effectiveness of newly developed RSV vaccines. Deliverables include a written report and presentation of findings by February 2023. The justification document cites the University of Michigan's expertise, existing data and models specific to RSV that allow completion of the required work by the December 2022 deadline. The total value of the sole source contract is $274,701 to be awarded on September 1, 2022.
75D30122P15319 Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services
9/15/22, 6:16 PM Notice of intent for sole source procurement of respiratory syncytial virus (RSV) Modeling, Cost Assessments, and Health Utility Analyses
This notice solicits research services from the Regents of the University of Michigan to conduct respiratory syncytial virus modeling, cost assessments, and health utility analyses. The Centers for Disease Control and Prevention seeks to procure these services to inform Advisory Committee on Immunization Practices decision making on RSV vaccine cost effectiveness. Key deliverables include a written report and presentation by February 2023. The University of Michigan is the only source capable of meeting the December 2022 deadline due to its expertise, data, and coding for respiratory disease modeling and existing RSV survey instruments. The submission deadline for capability statements, proposals, or quotations is July 14, 2022.
There is no set-aside designated for this procurement. The primary NAICS and PSC codes relate to research and development in the medical sciences. The Regents of the University of Michigan is identified as the incumbent and only potential awardee due to its unique experience and data. The period of performance involves continuous work through February 2023 to support the ACIP meeting. All work will be performed within the United States.
68389 Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services
7/7/22, 1:30 PM Notice of intent for sole source procurement of COVID-19 Modeling, Cost Assessments, and Health Utility Analyses
This notice is for a sole source procurement by the Centers for Disease Control and Prevention of research services from the Regents of the University of Michigan to develop mathematical models estimating the population burden of COVID-19 in the US. The contractor must also determine the potential cost-effectiveness of updated mRNA COVID-19 vaccines and deliver findings to the Advisory Committee on Immunization Practices by July 2023. The CDC will consider any capability statements, proposals, or quotations submitted by May 11, 2023 at 4:30pm Eastern to determine if other responsible sources exist.
There is no set-aside designated for this opportunity. The University of Michigan is the incumbent contractor under purchase order 75D30122P15319 and is the only source able to provide the required deliverables by the agency's deadline due to existing respiratory disease transmission and cost-effectiveness models, COVID-19 specific health utilities surveys, and necessary data and expertise. All work is to be performed in the United States.
76451 Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services
5/6/23, 5:56 PM